Home » Topics » BioWorld

BioWorld
RSS

FDA APPROVES MERIDIAN DIAGNOSTIC

July 22, 1992

DYNAGEN SIGNS DEAL WITH MUREX

July 22, 1992

BTGC's GROWTH HORMONE APPROVED IN ISRAEL

July 22, 1992

ENZON LICENSES DRUG TO TREAT FABRY'S

July 22, 1992

AMGEN'S EARNINGS LIVE UP TO FORECASTS

July 22, 1992

AMSTERDAM AIDS CONFERENCE: POSITIVE RESPONSE FROM MICROGENESYS VACCINE

July 22, 1992

AMEX INDEX UP

July 22, 1992

QUADRA LOGIC SEEKS JAPANESE APPROVAL

July 22, 1992

CYTRX ENROLLS FIRST PATIENT FOR STUDY

July 21, 1992

IMMUNEX TESTS TNF CANDIDATE FOR SEPSIS

July 21, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...